Agreement and diagnostic performance of a smartphone-based bilirubin assessment tool for screening neonatal hyperbilirubinemia - Report - MDSpire

Agreement and diagnostic performance of a smartphone-based bilirubin assessment tool for screening neonatal hyperbilirubinemia

  • By

  • Ya Zhao

  • Anlan Xu

  • Tonghui Suo

  • Fengqin Zhang

  • Mingwu Chen

  • June 19, 2026

  • 0 min

Share

Clinical Report: Evaluation of a Smartphone-Enabled Bilirubin Measurement Tool

Overview

This study evaluates a smartphone application for measuring bilirubin in neonates, comparing its performance with total serum bilirubin (TSB) and transcutaneous bilirubin (TcB). The findings indicate good agreement and diagnostic accuracy.

Background

Neonatal hyperbilirubinemia is prevalent and can lead to severe neurological injury if not promptly detected. Current methods for bilirubin assessment include TSB and TcB, with TSB being the reference standard. There is a need for accessible, non-invasive screening tools that can be used outside of clinical settings, particularly in resource-limited areas.

Data Highlights

MeasurementMean Difference (μmol/L)Area Under CurveSensitivitySpecificity
Mobile App-2.420.9360.9120.908
TcBN/A0.9370.8820.931

Key Findings

  • Mobile app-derived bilirubin measurements showed a mean difference of -2.42 μmol/L compared to TSB.
  • Agreement between mobile app-derived bilirubin and TSB was lower in preterm infants compared to term infants.
  • Mobile app-derived bilirubin was positively correlated with TSB (R2 = 0.776, P < 0.001).
  • The mobile application achieved a sensitivity of 0.912 and specificity of 0.908.
  • TcB achieved a sensitivity of 0.882 and specificity of 0.931.

Clinical Implications

Further validation in diverse settings is necessary to confirm the utility of the smartphone application for screening neonatal hyperbilirubinemia.

Conclusion

The study demonstrates that a smartphone application for bilirubin measurement can provide reliable results comparable to established methods.

Related Resources & Content

  1. Frontiers in Pediatrics, 2026 -- A LASSO-Based Nomogram for Predicting Acute Bilirubin Encephalopathy in Newborns with Severe Hyperbilirubinemia
  2. The New Gastroenterologist, 2025 -- Smartphone-Enabled Fecal Test for Colorectal Cancer Screening Demonstrates Lab-Equivalent Accuracy
  3. Frontiers in Pediatrics, 2026 -- Predicting neurodevelopmental outcomes in neonatal hyperbilirubinemia: a multidimensional nomogram integrating biomarkers and neurobehavioral scores
  4. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation | Pediatrics | American Academy of Pediatrics
  5. Smartphone-based screening of neonatal jaundice in three populations in low and middle-income countries: a cross-sectional study
  6. Frontiers in Pediatrics — Skin residual bilirubin volume: a physiologically informed framework for transcutaneous bilirubin interpretation in neonates
  7. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation | Pediatrics | American Academy of Pediatrics
  8. Smartphone-based screening of neonatal jaundice in three populations in low and middle-income countries: a cross-sectional study
  9. Performance of smartphone application to accurately quantify hyperbilirubinemia in neonates: a systematic review with meta-analysis - PubMed

Original Source(s)

Related Content